-
Pharma Pollution: Shut The Back Door On Superbugs
EPHA and Changing Markets unveils how the pharmaceutical industry’s role in contributing to the spread of antimicrobial resistance (AMR) via pollution of the environment in a new briefing. The failure to produce drugs responsibly and ensure transparency and respect for environmental standards in global supply chains is contributing to the proliferation of drug-resistant infections.
- Categories
- Environment, Health Care
-
OraSure gets Zika funding
OraSure Technologies will get federal funding to develop a Zika test despite Congress' failure to allocate money to fight the mosquito-borne disease. The south Bethlehem diagnostics company announced Tuesday it had been awarded a contract for up to $16.6 million from the U.S. Department of Health and Human Services.
- Categories
- Health Care
-
Paper-based Test Identifies Bogus and Poor Quality Drugs
Counterfeit and substandard medications are a serious problem in the developing world, potentially harming patients who desperately need medical treatment. Some of these drugs — including the antibiotics ciprofloxacin and ceftriaxone — have been deemed essential by the World Health Organization for the treatment of infections.
- Categories
- Health Care
-
As globe-threatening yellow fever epidemic explodes in Congo, people ask ‘where is the vaccine?’
Here in Kinshasa, they’re using bug spray to repel a pandemic. At first glance, it looks like a bloody ambush on civilians: Dozens in uniform are storming into a bustling marketplace bearing on their shoulders what look like bazookas.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
The Price of Zika? About $4 Million Per Child
TO TALK ABOUT Zika virus control is to talk about money. Vaccine development, mosquito abatement, and even the distribution of DEET repellant takes (and currently lacks) major federal dollars. When, last week, the US Department of Health and Human Services declared Zika a public health emergency in Puerto Rico, it was in part a means to a better-funded end.
- Categories
- Health Care
-
U.S. Court Upholds United Nations’ Immunity in Cholera Suit
A United States federal appeals panel has upheld that the United Nations cannot be sued in American courts, dealing a setback in a class-action lawsuit brought on behalf of thousands of cholera victims in Haiti.
- Categories
- Health Care
- Region
- North America
-
One Innovative Company is Helping the Fight Against Dengue
Philab Industries, a pioneer in the healthcare business in the Philippines, is expanding to healthcare science and technology bringing in the most advanced diagnostic tools to the country.
- Categories
- Health Care
- Region
- South Asia
-
The race for a Zika vaccine is intense. But it may be missing the most important players
About a year ago, before the Zika virus grabbed global attention, there were zero vaccines for it in development. Today, according to the World Health Organization, there are 30. Some of the work has been astonishingly quick. Human trials for two experimental vaccines have already begun.
- Categories
- Health Care
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.